Quarterly report [Sections 13 or 15(d)]

Stockholders’ Equity (Tables)

v3.26.3
Stockholders’ Equity (Tables)
 9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
Summary of Share-Based Compensation Expense The following table sets forth share-based compensation expense included in the condensed consolidated statements of operations:

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

(in thousands)

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Cost of revenue

 

$

37

 

 

$

31

 

 

$

141

 

 

$

100

 

Research and development costs

 

 

513

 

 

 

501

 

 

 

1,485

 

 

 

1,558

 

Sales and marketing expenses

 

 

630

 

 

 

550

 

 

 

1,948

 

 

 

1,674

 

General and administrative expenses

 

 

700

 

 

 

940

 

 

 

2,795

 

 

 

2,867

 

Total share-based compensation expense

 

$

1,880

 

 

$

2,022

 

 

$

6,369

 

 

$

6,199

 

Share-based compensation expense by type of share-based award is summarized below:

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

(in thousands)

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Stock options

 

$

—

 

 

$

40

 

 

$

28

 

 

$

233

 

RSAs and RSUs

 

 

1,782

 

 

 

1,923

 

 

 

5,974

 

 

 

5,765

 

ESPP

 

 

98

 

 

 

59

 

 

 

367

 

 

 

201

 

Total share-based compensation expense

 

$

1,880

 

 

$

2,022

 

 

$

6,369

 

 

$

6,199

 

 

Total unrecognized compensation expense by type of award and the weighted-average remaining requisite service period over which such expense is expected to be recognized:

 

September 30, 2026

 

 

Unrecognized
Expense
(in thousands)

 

 

Remaining
Weighted-
Average
Recognition
Period (in years)

 

RSUs

 

$

11,428

 

 

 

1.87

 
Summary of Stock Option Activity

Stock option activity for the nine months ended September 30, 2026 is summarized below:

 

Stock
Options

 

 

Weighted-
average
Exercise
price
per share

 

 

Weighted-
average
Remaining
Contractual
Life (in years)

 

 

Intrinsic
Value
(in thousands)(1)

 

Outstanding as of December 31, 2025

 

 

1,302,072

 

 

$

5.78

 

 

 

 

 

 

 

Exercised

 

 

(229,388

)

 

$

3.29

 

 

 

 

 

 

 

Forfeited or expired

 

 

(38,144

)

 

$

15.81

 

 

 

 

 

 

 

Outstanding as of September 30, 2026

 

 

1,034,540

 

 

$

5.96

 

 

 

3.25

 

 

$

6,994

 

Exercisable as of September 30, 2026

 

 

1,034,540

 

 

$

5.96

 

 

 

3.25

 

 

$

6,994

 

 

(1)

Intrinsic value is calculated as the estimated fair value of the Company’s stock at the end of the related period less the option exercise price of in-the-money options.
Schedule of Restricted Stock Unit Activity

Restricted Stock Unit Activity

Restricted stock unit activity for the nine months ended September 30, 2026 is summarized below:

 

Restricted Stock
Units

 

 

Weighted-
Average
Grant
Date Fair Value

 

Outstanding as of December 31, 2025

 

 

1,651,867

 

 

$

9.16

 

Granted

 

 

785,662

 

 

$

13.34

 

Vested

 

 

(842,968

)

 

$

8.30

 

Forfeited or expired

 

 

(131,116

)

 

$

11.89

 

Outstanding as of September 30, 2026

 

 

1,463,445

 

 

$

11.65